Papo M - Search Results

1

Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease.

Casellas F, Barreiro de Acosta M, Iglesias M, Robles V, Nos P, Aguas M, Riestra S, de Francisco R, Papo M, Borruel N. Casellas F, et al. Among authors: papo m. Eur J Gastroenterol Hepatol. 2012 Jul;24(7):762-9. doi: 10.1097/MEG.0b013e32835414b2. Eur J Gastroenterol Hepatol. 2012. PMID: 22517240

2

Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study.

Casellas F, Arenas JI, Baudet JS, Fábregas S, García N, Gelabert J, Medina C, Ochotorena I, Papo M, Rodrigo L, Malagelada JR. Casellas F, et al. Among authors: papo m. Inflamm Bowel Dis. 2005 May;11(5):488-96. doi: 10.1097/01.mib.0000159661.55028.56. Inflamm Bowel Dis. 2005. PMID: 15867589

3

Factors that impact health-related quality of life in adults with celiac disease: a multicenter study.

Casellas F, Rodrigo L, Vivancos JL, Riestra S, Pantiga C, Baudet JS, Junquera F, Diví VP, Abadia C, Papo M, Gelabert J, Malagelada JR. Casellas F, et al. Among authors: papo m. World J Gastroenterol. 2008 Jan 7;14(1):46-52. doi: 10.3748/wjg.14.46. World J Gastroenterol. 2008. PMID: 18176960 Free PMC article.

4

Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.

Casellas F, Papo M, Guarner F, Antolín M, Segura RM, Armengol JR, Malagelada JR. Casellas F, et al. Among authors: papo m. Eur J Gastroenterol Hepatol. 1995 Mar;7(3):221-6. Eur J Gastroenterol Hepatol. 1995. PMID: 7743303

5

6-mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine.

Domènech E, Nos P, Papo M, López-San Román A, Garcia-Planella E, Gassull MA. Domènech E, et al. Among authors: papo m. Scand J Gastroenterol. 2005 Jan;40(1):52-5. doi: 10.1080/00365520410009492. Scand J Gastroenterol. 2005. PMID: 15841714

6

Antiinflammatory effects of enterically coated amoxicillin-clavulanic acid in active ulcerative colitis.

Casellas F, Borruel N, Papo M, Guarner F, Antolín M, Videla S, Malagelada JR. Casellas F, et al. Among authors: papo m. Inflamm Bowel Dis. 1998 Feb;4(1):1-5. doi: 10.1097/00054725-199802000-00001. Inflamm Bowel Dis. 1998. PMID: 9552221 Clinical Trial.

7

Usefulness of rectal dialysis to determine intrarectal eicosanoids release in ulcerative colitis.

Casellas F, Borruel N, Papo M, Antolín M, Armengol JR, Malagelada JR. Casellas F, et al. Among authors: papo m. Rev Esp Enferm Dig. 1997 Apr;89(4):280-8. Rev Esp Enferm Dig. 1997. PMID: 9168661 Clinical Trial. English, Spanish.

8

Intracolonic release in vivo of interleukin-1 beta in chronic ulcerative colitis.

Casellas F, Papo M, Guarner F, Antolín M, Segura RM, Armengol JR, Malagelada JR. Casellas F, et al. Among authors: papo m. Clin Sci (Lond). 1995 Nov;89(5):521-6. doi: 10.1042/cs0890521. Clin Sci (Lond). 1995. PMID: 8549067

9

Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies.

Papo M, Quer JC, Gutierrez C, Broch M, Casellas F, Pastor RM, Olona M, Richart C. Papo M, et al. Eur J Gastroenterol Hepatol. 1999 Apr;11(4):413-20. doi: 10.1097/00042737-199904000-00010. Eur J Gastroenterol Hepatol. 1999. PMID: 10321759

10

Intraluminal colonic release of immunoreactive tumour necrosis factor in chronic ulcerative colitis.

Casellas F, Papo M, Guarner F, Antolín M, Armengol JR, Malagelada JR. Casellas F, et al. Among authors: papo m. Clin Sci (Lond). 1994 Oct;87(4):453-8. doi: 10.1042/cs0870453. Clin Sci (Lond). 1994. PMID: 7834999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters